Delta Plus variant is one of the three subtypes of the Covid Delta variant. Scientists have classified B.1.617.2 (Delta Plus) as a 'variant of Concern' because it has increased transmissibility.
The other characteristics of the DeltaPlus variant include: Stronger binding to receptors of lung cells; Potential reduction in monoclonal antibody response and Potential post-vaccination immune escape.
Both Delta and Delta Plus variants are the results of mutation in coronavirus. The Delta Plus variant has an additional mutation in comparison to the Delta variant; this mutation has been named the K417N mutation.
According to a study published in the Journal of Infection on August 17 and approved by the Institutional Ethics Committee of